Skip to main content
Year archive

IMUGENE LIMITED — 2018 filings

All 66 regulatory filings released by IMUGENE LIMITED (IMU) in 2018, sourced directly from the official regulator.

66 Filings
2018 Period
2018 filings (66)
Filing Released Lang
Change of Director's Interest Notice - PH 2 pages 368.2KB
Director's Dealing
2018-12-19 English
IMU Meets Endpoints in Phase 1b Gastric Cancer Trial 4 pages 114.5KB
Regulatory Filings
2018-12-16 English
Change of Director's Interest Notice - PH 2 pages 183.0KB
Director's Dealing
2018-11-20 English
Appendix 3B and 708A Notice 14 pages 542.5KB
Share Issue/Capital Change
2018-11-20 English
Change of Director's Interest Notice - LC 2 pages 182.7KB
Director's Dealing
2018-11-20 English
Imugene Advances to Phase 2 in Gastric Cancer Trial 4 pages 372.0KB
Regulatory Filings
2018-11-12 English
AGM Presentation 12 pages 2.1MB
AGM Information
2018-11-12 English
Results of Meeting 1 page 139.0KB
Declaration of Voting Results & Voting Rights Announcements
2018-11-12 English
Imugene Receives $1.85 million R&D Tax Incentive 2 pages 105.6KB
Capital/Financing Update
2018-11-08 English
Appendix 4C - quarterly 7 pages 997.7KB
Interim / Quarterly Report
2018-10-29 English
Appendix 3B (Exercise of Options) and 708A Notice 14 pages 551.7KB
Capital/Financing Update
2018-10-21 English
Change of Director's Interest Notice - AH 3 pages 482.2KB
Director's Dealing
2018-10-21 English
Notice of Annual General Meeting/Proxy Form 24 pages 827.2KB
AGM Information
2018-10-08 English
Change in Executive Remuneration 3 pages 346.4KB
Remuneration Information
2018-10-07 English
ESMO President joins Imugene Scientific Advisory Board 2 pages 132.0KB
Board/Management Information
2018-10-03 English
Imugene appoints leading cancer researcher to SAB 2 pages 322.7KB
Board/Management Information
2018-09-30 English
Annual Report to shareholders 75 pages 4.2MB
Annual Report
2018-09-27 English
Appendix 4G 10 pages 155.2KB
Regulatory Filings
2018-09-27 English
Imugene commences cGMP manufacture of PD-1 cancer vaccine 2 pages 140.1KB
Capital/Financing Update
2018-09-20 English
Imugene appoints gastrointestinal cancer expert to SAB 2 pages 59.6KB
Board/Management Information
2018-09-17 English
Imugene Completes Phase 1b Cancer Vaccine Trial Recruitment 4 pages 401.2KB
Regulatory Filings
2018-09-10 English
Appendix 4E and Audited Financial Report 63 pages 542.5KB
Annual Report
2018-08-30 English
Imugene appoints Dr Mark Marino Chief Medical Officer 2 pages 406.9KB
Board/Management Information
2018-08-22 English
Appendix 4C - Quarterly and Business Update 7 pages 569.2KB
Interim / Quarterly Report
2018-07-30 English
2018 Bioshares Presentation 16 pages 5.3MB
Investor Presentation
2018-07-26 English
Change of Director's Interest Notice - PH 2 pages 38.8KB
Director's Dealing
2018-07-23 English
Change of Director's Interest Notice - LC 2 pages 38.8KB
Director's Dealing
2018-07-23 English
PD-1 cancer vaccine development update 2 pages 406.3KB
Regulatory Filings
2018-07-22 English
Appendix 3B ESOP 13 pages 107.6KB
Share Issue/Capital Change
2018-07-19 English
Change of Director's Interest Notice - PH 2 pages 38.8KB
Director's Dealing
2018-07-19 English
Appendix 3B 13 pages 108.4KB
Capital/Financing Update
2018-07-15 English
Appendix 3B and 708A Notice 14 pages 1.5MB
Capital/Financing Update
2018-07-11 English
Change of Director's Interest Notice - PH 2 pages 39.1KB
Director's Dealing
2018-07-11 English
Change of Director's Interest Notice - LC 2 pages 39.0KB
Director's Dealing
2018-07-11 English
Change of Director's Interest Notice - CW 2 pages 39.1KB
Director's Dealing
2018-07-11 English
Becoming a substantial holder 4 pages 109.0KB
Regulatory Filings
2018-07-09 English
General Meeting Presentation 10 pages 1.0MB
Investor Presentation
2018-07-08 English
Results of Meeting 1 page 869.5KB
Declaration of Voting Results & Voting Rights Announcements
2018-07-08 English
Rights Issue Results & Shortfall Notification 1 pag
Capital/Financing Update
2018-07-05 English
Appendix 3B (Exercise of Options) and 708A Notice 15 pages 946.8KB
Capital/Financing Update
2018-06-13 English
Response to ASX Query 4 pages 509.4KB
Regulatory Filings
2018-06-07 English
Imugene Licences Extensive B-Cell Immuno-Oncology Portfolio 3 pages 348.1KB
Capital/Financing Update
2018-06-06 English
IMUGENE RAISES $20.1 MILLION 8 pages 593.5KB
Capital/Financing Update
2018-06-06 English
Capital Raising Presentation 24 pages 1.6MB
Investor Presentation
2018-06-06 English
Prospectus 45 pages 999.0KB
Capital/Financing Update
2018-06-06 English
Appendix 3B 13 pages 797.2KB
Capital/Financing Update
2018-06-06 English
Imugene Entitlement Offer notice to eligible shareholders 4 pages 314.1KB
Capital/Financing Update
2018-06-06 English
Imugene Entitlement Offer notice to ineligible shareholders 3 pages 309.5KB
Capital/Financing Update
2018-06-06 English
Imugene Entitlement Offer notice to option holders 3 pages 310.4KB
Capital/Financing Update
2018-06-06 English
Notice of General Meeting/Proxy Form 12 pages 1.2MB
Proxy Solicitation & Information Statement
2018-06-06 English
Trading Halt 2 pages 454.1KB
Capital/Financing Update
2018-06-04 English
Appendix 4C - quarterly 5 pages 672.6KB
Interim / Quarterly Report
2018-04-25 English
Ceasing to be a substantial holder from PTM 3 pages 140.7KB
Director's Dealing
2018-04-12 English
Initial Director's Interest Notice - LC 2 pages 29.9KB
Director's Dealing
2018-03-28 English
Leslie Chong Appointed as Managing Director 1 page
Board/Management Information
2018-03-27 English
Change in substantial holding 4 pages 169.0KB
Regulatory Filings
2018-03-12 English
Change in substantial holding 4 pages 172.7KB
Regulatory Filings
2018-03-12 English
Half Yearly Report and Accounts 19 pages 207.1KB
Interim / Quarterly Report
2018-02-26 English
Arginine Modulator Active in Cancer Models 2 pages 244.2KB
Regulatory Filings
2018-02-18 English
Novel Anti-PD-1 Mimotope Vaccine Ready for Development 2 pages 168.1KB
Regulatory Filings
2018-02-11 English
IMU Meets Investigator for Gastric Cancer Clinical Trial 2 pages 45.0KB
Regulatory Filings
2018-02-08 English
Cancer vaccine shows early promise in clinical trial 2 pages 240.9KB
Regulatory Filings
2018-02-06 English
Change in substantial holding 4 pages 164.6KB
Regulatory Filings
2018-02-05 English
Change in substantial holding 3 pages 95.1KB
Regulatory Filings
2018-02-05 English
Business Update - December Quarter Appendix 4C 7 pages 1.0MB
Interim / Quarterly Report
2018-01-28 English
SF Biotech Presentation 34 pages 1.9MB
Investor Presentation
2018-01-08 English